Emilia Antonucci

5.1k total citations · 1 hit paper
115 papers, 3.4k citations indexed

About

Emilia Antonucci is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Emilia Antonucci has authored 115 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Cardiology and Cardiovascular Medicine, 61 papers in Internal Medicine and 19 papers in Surgery. Recurrent topics in Emilia Antonucci's work include Atrial Fibrillation Management and Outcomes (71 papers), Venous Thromboembolism Diagnosis and Management (61 papers) and Antiplatelet Therapy and Cardiovascular Diseases (30 papers). Emilia Antonucci is often cited by papers focused on Atrial Fibrillation Management and Outcomes (71 papers), Venous Thromboembolism Diagnosis and Management (61 papers) and Antiplatelet Therapy and Cardiovascular Diseases (30 papers). Emilia Antonucci collaborates with scholars based in Italy, United Kingdom and United States. Emilia Antonucci's co-authors include Daniela Poli, Sophie Testa, Gualtiero Palareti, Domenico Prisco, Alberto Tosetto, Benilde Cosmi, Cristina Legnani, Rossella Marcucci, Rosanna Abbate and Gian Franco Gensini and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Emilia Antonucci

109 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison between different D‐Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study

2015 645 citations Gualtiero Palareti, Cristina Legnani et al. International Journal of Laboratory Hematology profile →

Peers

Countries citing papers authored by Emilia Antonucci

Since Specialization

Citations

This map shows the geographic impact of Emilia Antonucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilia Antonucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilia Antonucci more than expected).

Fields of papers citing papers by Emilia Antonucci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emilia Antonucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilia Antonucci. The network helps show where Emilia Antonucci may publish in the future.

Co-authorship network of co-authors of Emilia Antonucci

This figure shows the co-authorship network connecting the top 25 collaborators of Emilia Antonucci. A scholar is included among the top collaborators of Emilia Antonucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emilia Antonucci. Emilia Antonucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 2024 ·International Journal of Laboratory Hematology ·(unknown), (unknown), Gilda Sandri, Daniela Poli, Piera Sivera, (unknown), Domenico Prisco, (unknown), (unknown), Emilia Antonucci, Gualtiero Palareti, Vittorio Pengo, (unknown)	2
2	The use of reduced DOAC doses in atrial fibrillation patients does not always lead to good anticoagulation levels and avoid adverse events 2024 ·International Journal of Cardiology ·Gualtiero Palareti, Sophie Testa, Cristina Legnani, Oriana Paoletti, Michela Cini, Emilia Antonucci, Vittorio Pengo, Daniela Poli, Walter Ageno, Paolo Prandoni, Domenico Prisco, Alberto Tosetto	1
3	Renin‐angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registry 2023 ·European Journal of Internal Medicine ·Danilo Menichelli, Daniela Poli, Emilia Antonucci, Gualtiero Palareti, Pasquale Pignatelli, Daniele Pastori	5
4	Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register 2020 ·BMJ Open ·Gualtiero Palareti, Emilia Antonucci, Cristina Legnani, Daniela Mastroiacovo, Daniela Poli, Paolo Prandoni, Alberto Tosetto, Vittorio Pengo, Sophie Testa, Walter Ageno	9
5	Determinants of low‐quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study 2020 ·British Journal of Haematology ·Daniele Pastori, Gregory Y.H. Lip, Daniela Poli, Emilia Antonucci, Luca Rubino, Danilo Menichelli, Mirella Saliola, Francesco Violi, Gualtiero Palareti, Pasquale Pignatelli	13
6	Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs 2020 ·European Journal of Internal Medicine ·Daniela Poli, Emilia Antonucci, (unknown), (unknown), Sophie Testa, Paolo Simioni, Vittorio Pengo, Pasquale Pignatelli, Anna Falanga, (unknown), Doris Barcellona, Antonio Ciampa, (unknown), (unknown), Walter Ageno, Gualtiero Palareti	6
7	Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism 2020 ·Internal and Emergency Medicine ·Gualtiero Palareti, Cristina Legnani, Emilia Antonucci, (unknown), A Bignamini, Corrado Lodigiani, Alberto Tosetto, Lorenza Bertù, Vittorio Pengo, Sophie Testa, Walter Ageno, Domenico Prisco, Paolo Prandoni, Daniela Poli	4
8	Optimal Medical Therapy on Top of Dual-Antiplatelet Therapy: 1-Year Clinical Outcome in Patients With Acute Coronary Syndrome: The START Antiplatelet Registry 2019 ·Angiology ·Plinio Cirillo, Luigi Di Serafino, (unknown), Paolo Calabrò, Emilia Antonucci, Paolo Gresele, Gualtiero Palareti, Giuseppe Patti, Vittorio Pengo, Pasquale Pignatelli, Rossella Marcucci	2
9	Oral anticoagulation in very elderly patients with atrial fibrillation: Results from the prospective multicenter START2-REGISTER study 2019 ·PLoS ONE ·Daniela Poli, Emilia Antonucci, Walter Ageno, Lorenza Bertù, Ludovica Migliaccio, (unknown), (unknown), Sophie Testa, Gualtiero Palareti	18
10	Epidemiology and Management of Patients With Acute Coronary Syndromes in Contemporary Real-World Practice: Evolving Trends From the EYESHOT Study to the START-ANTIPLATELET Registry 2018 ·Angiology ·Paolo Calabrò, Felice Gragnano, Marco Di Maio, Giuseppe Patti, Emilia Antonucci, Plinio Cirillo, Paolo Gresele, Gualtiero Palareti, Vittorio Pengo, Pasquale Pignatelli, Mauro Pennacchi, Antonino Granatelli, Stefano De Servi, Leonardo De Luca, Rossella Marcucci, (unknown)	28
11	Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study 2018 ·International Journal of Cardiology ·Daniela Poli, Emilia Antonucci, Vittorio Pengo, Ludovica Migliaccio, Sophie Testa, Corrado Lodigiani, (unknown), (unknown), (unknown), Pietro Falco, (unknown), (unknown), L. Ruocco, Raffaele De Caterina, Gualtiero Palareti	31
12	Gender-Related Differences in Antiplatelet Therapy and Impact on 1-Year Clinical Outcome in Patients Presenting With ACS: The START ANTIPLATELET Registry 2018 ·Angiology ·Plinio Cirillo, Luigi Di Serafino, Giuseppe Patti, Emilia Antonucci, Paolo Calabrò, Paolo Gresele, Gualtiero Palareti, Vittorio Pengo, Pasquale Pignatelli, Rossella Marcucci	18
13	Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago 2017 ·Internal and Emergency Medicine ·Gualtiero Palareti, Emilia Antonucci, Ludovica Migliaccio, Nicoletta Erba, Francesco Marongiu, Vittorio Pengo, Daniela Poli, Sophie Testa, Alberto Tosetto, Armando Tripodi, Marco Moia	30
14	External validation of the DASH prediction rule: a retrospective cohort study 2017 ·Journal of Thrombosis and Haemostasis ·Alberto Tosetto, Sophie Testa, Ida Martinelli, Daniela Poli, Benilde Cosmi, Corrado Lodigiani, Walter Ageno, Valerio De Stefano, Anna Falanga, Ilaria Nichele, Oriana Paoletti, Paolo Bucciarelli, Emilia Antonucci, Cristina Legnani, Elena Banfi, Francesco Dentali, (unknown), Luca Barcella, Gualtiero Palareti	50
15	Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score 2015 ·Internal and Emergency Medicine ·Daniele Pastori, Alessio Farcomeni, Daniela Poli, Emilia Antonucci, Francesco Angelico, Maria Del Ben, Roberto Cangemi, Gaetano Tanzilli, Gregory Y.H. Lip, Pasquale Pignatelli, Francesco Violi	40
16	The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation 2015 ·PLoS ONE ·Emilia Antonucci, Daniela Poli, Alberto Tosetto, Vittorio Pengo, Armando Tripodi, Nicola Magrini, Francesco Marongiu, Gualtiero Palareti, (unknown)	40
17	The balance between pro- and anti-inflammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients 2008 ·Atherosclerosis ·Anna Maria Gori, Francesca Cesari, Rossella Marcucci, Betti Giusti, Rita Paniccia, Emilia Antonucci, Gian Franco Gensini, Rosanna Abbate	70
18	Renal transplant recipients are at high risk for both symptomatic and asymptomatic deep vein thrombosis 2006 ·Journal of Thrombosis and Haemostasis ·Daniela Poli, M. Zanazzi, Emilia Antonucci, E. Bertoni, Maurizio Salvadori, (unknown), Domenico Prisco	47
19	Culprit Factors for the Failure of Well-Conducted Warfarin Therapy to Prevent Ischemic Events in Patients With Atrial Fibrillation 2005 ·Stroke ·Daniela Poli, Emilia Antonucci, Emanuele Cecchi, Rossella Marcucci, Agatina Alessandrello Liotta, Anna Paola Cellai, (unknown), Gian Franco Gensini, Rosanna Abbate, Domenico Prisco	52
20	Hirudins for Prophylaxis and Treatment of Venous Thromboembolism 2001 ·Seminars in Thrombosis and Hemostasis ·Domenico Prisco, Michela Falciani, Emilia Antonucci, G. F. Gensini	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact